Karen Luk
Nessuna posizione attualmente
Profilo
Karen Luk worked as a Manager-SEC Reporting at Onyx Pharmaceuticals, Inc. and Portola Pharmaceuticals, Inc. before becoming a Senior Manager-SEC Reporting at Pattern Energy Group, Inc. She then worked as a Controller at CounterPath Corp.
from 2018 to 2019.
Ms. Luk received an undergraduate degree from Simon Fraser University.
Precedenti posizioni note di Karen Luk
| Società | Posizione | Fine |
|---|---|---|
| COUNTERPATH CORPORATION | Direttore Finanziario/CFO | 16/09/2020 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - |
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| PATTERN ENERGY GROUP INC. | Corporate Officer/Principal | - |
Formazione di Karen Luk
| Simon Fraser University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
CounterPath Corp.
 CounterPath Corp. Packaged SoftwareTechnology Services CounterPath Corp. engages in the provision of desktop and mobile VoIP software products and solutions. Its product suite includes SIP-based softphones, server applications, and Fixed Mobile Convergence (FMC) solutions. The company was founded by Mark E. Bruk on October 28, 2002 and is headquartered in Vancouver, Canada. | Technology Services |
Pattern Energy Group, Inc.
 Pattern Energy Group, Inc. Alternative Power GenerationUtilities Pattern Energy Group, Inc. is an independent power company, which owns and operates wind and solar power facilities sales contracts. It operates through the following geographical segments: United States, Canada, and Chile. The company was founded in 2009 and is headquartered in San Francisco, CA. | Utilities |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Borsa valori
- Insiders
- Karen Luk
